Potassium and risk of Type 2 diabetes

References

• Dall T, Mann SE, Zhang Y et al. Economic costs of diabetes in the U.S. in 2007. Diabetes Care31(3), 596–615 (2008).
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care27(5), 1047–1053 (2004).
   PubMed Web of Science ®Google Scholar
• Stern MP, Haffner SM. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis6(2), 123–130 (1986).
   PubMedGoogle Scholar
• Martini LA, Catania AS, Ferreira SR. Role of vitamins and minerals in prevention and management of Type 2 diabetes mellitus. Nutr. Rev.68(6), 341–354 (2010).
   PubMed Web of Science ®Google Scholar
• Hectors TL, Vanparys C, van der Ven K et al. Environmental pollutants and Type 2 diabetes: a review of mechanisms that can disrupt β cell function. Diabetologia54(6), 1273–1290 (2011).
   PubMed Web of Science ®Google Scholar
• Grant RW, Moore AF, Florez JC. Genetic architecture of Type 2 diabetes: recent progress and clinical implications. Diabetes Care32(6), 1107–1114 (2009).
   PubMed Web of Science ®Google Scholar
• Corry DB, Tuck ML. The effect of aldosterone on glucose metabolism. Curr. Hypertens. Rep.5(2), 106–109 (2003).
   PubMed Web of Science ®Google Scholar
• Conn JW. Hypertension, the potassium ion and impaired carbohydrate tolerance. N. Engl. J. Med.273(21), 1135–1143 (1965).
   PubMed Web of Science ®Google Scholar
• Carter BL, Einhorn PT, Brands M et al. Thiazide-induced dysglycemia: call for research from a working group from the National Heart, Lung, and Blood institute. Hypertension52, 30–36 (2008).
   PubMed Web of Science ®Google Scholar
• Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension48(2), 219–224 (2006).
   PubMed Web of Science ®Google Scholar
• Rapoport MI, Hurd HF. Thiazide-induced glucose intolerance treated with potassium. Arch. Intern. Med.113, 405–408 (1964).
   PubMed Web of Science ®Google Scholar
• Jackson JH, Sobolski J, Krienke R, Wong KS, Frech-Tamas F, Nightengale B. Blood pressure control and pharmacotherapy patterns in the United States before and after the release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines. J. Am. Board Fam. Med.21(6), 512–521 (2008).
   PubMed Web of Science ®Google Scholar
• Chatterjee R, Yeh HC, Shafi T et al. Serum and dietary potassium and risk of incident Type 2 diabetes mellitus: the Atherosclerosis Risk in Communities (ARIC) study. Arch. Intern. Med.170, 1745–1751 (2010).
   PubMedGoogle Scholar
• Heianza Y, Hara S, Arase Y et al. Low serum potassium levels and risk of Type 2 diabetes: the Toranomon Hospital Health Management Center Study 1 (TOPICS1). Diabetologia54(4), 762–766 (2011).
   PubMedGoogle Scholar
• Evans KJ, Greenberg A. Hyperkalemia: a review. J. Intensive Care Med.20(5), 272–290 (2005).
   PubMedGoogle Scholar
• Panel on Dietary Reference Intakes for Electrolytes and Water; The Standing Committee on the Scientific Evaluation of Dietary Reference Intakes; National Academy of Sciences. Chapter 5: Potassium. In: Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. The National Academies Press, Washington DC, USA, 186–268 (2004).
   Google Scholar
• Gorden P. Glucose intolerance with hypokalemia. Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia. Diabetes22(7), 544–551 (1973).
   PubMed Web of Science ®Google Scholar
• Helderman JH, Elahi D, Andersen DK, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes32(2), 106–111 (1983).
   PubMed Web of Science ®Google Scholar
• Rowe JW, Tobin JD, Rosa RM, Andres R. Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism29(6), 498–502 (1980).
   PubMed Web of Science ®Google Scholar
• The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA288(23), 2981–2997 (2002).
   PubMed Web of Science ®Google Scholar
• Taylor EN, Hu FB, Curhan GC. Antihypertensive medications and the risk of incident Type 2 diabetes. Diabetes Care29(5), 1065–1070 (2006).
   PubMed Web of Science ®Google Scholar
• Burke TA, Sturkenboom MC, Ohman-Strickland PA, Wentworth CE, Rhoads GG. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset Type 2 diabetes mellitus. Pharmacoepidemiol. Drug Saf.16(9), 979–987 (2007).
   PubMed Web of Science ®Google Scholar
• Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for Type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N. Engl. J. Med.342(13), 905–912 (2000).
   PubMed Web of Science ®Google Scholar
• Donahue RP, Abbott RD, Wilson PW. Effect of diuretic use on the development of diabetes mellitus. The Framingham study. Horm. Metab. Res. Suppl.22, 46–48 (1990).
   PubMedGoogle Scholar
• Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet369(9557), 201–207 (2007).
   PubMed Web of Science ®Google Scholar
• Shafi T, Appel LJ, Miller ER, Klag MJ, Parekh RS. Changes in serum potassium mediate thiazide-induced diabetes Hypertension52, 1022–1029 (2008).
   PubMed Web of Science ®Google Scholar
• Eriksson JW, Jansson PA, Carlberg B et al. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) study. Hypertension52(6), 1030–1037 (2008).
   PubMed Web of Science ®Google Scholar
• Bakris G, Molitch M, Hewkin A et al. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome. Diabetes Care29(12), 2592–2597 (2006).
   PubMed Web of Science ®Google Scholar
• Bosch J, Yusuf S, Gerstein HC et al. Effect of ramipril on the incidence of diabetes. N. Engl. J. Med.355(15), 1551–1562 (2006).
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Holman RR, Haffner SM et al. Effect of valsartan on the incidence of diabetes and cardiovascular events. N. Engl. J. Med.362(16), 1477–1479 (2010).
   PubMed Web of Science ®Google Scholar
• Weir MR, Rolfe M. Potassium homeostasis and renin–angiotensin–aldosterone system inhibitors. Clin. J. Am. Soc. Nephrol.5(3), 531–548 (2010).
   PubMed Web of Science ®Google Scholar
• Barzilay JI, Davis BR, Cutler JA et al. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch. Intern. Med.166(20), 2191–2201 (2006).
   PubMed Web of Science ®Google Scholar
• Andraws R, Brown DL. Effect of inhibition of the renin–angiotensin system on development of Type 2 diabetes mellitus (meta-analysis of randomized trials). Am. J. Cardiol.99(7), 1006–1012 (2007).
   PubMed Web of Science ®Google Scholar
• Tocci G, Paneni F, Palano F et al. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials. Am. J. Hypertens.24(5), 582–590 (2011).
   PubMedGoogle Scholar
• McGuire DK, Winterfield JR, Rytlewski JA et al. Blocking the renin–angiotensin–aldosterone system to prevent diabetes mellitus. Diab. Vasc. Dis. Res.5(1), 59–66 (2008).
   PubMed Web of Science ®Google Scholar
• Hershon KS. Mechanistic and clinical aspects of renin-angiotensin-aldosterone system (RAAS) blockade in the prevention of diabetes and cardiovascular disease. Endocr. Pract.17(3), 430–440 (2011).
   PubMedGoogle Scholar
• Santoro D, Natali A, Palombo C et al. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension. Hypertension20(2), 181–191 (1992).
   PubMed Web of Science ®Google Scholar
• Chatterjee R, Yeh HC, Shafi T et al. Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr.93(5), 1087–1091 (2011).
   PubMed Web of Science ®Google Scholar
• Bingham SA, Day NE. Using biochemical markers to assess the validity of prospective dietary assessment methods and the effect of energy adjustment. Am. J. Clin. Nutr.65(4 Suppl.), 1130S–1137S (1997).
   PubMed Web of Science ®Google Scholar
• Liu K, Slattery M, Jacobs D Jr et al. A study of the reliability and comparative validity of the CARDIA dietary history. Ethn. Dis.4(1), 15–27 (1994).
   PubMedGoogle Scholar
• Tasevska N, Runswick SA, Bingham SA, Urinary potassium is as reliable as urinary nitrogen for use as a recovery biomarker in dietary studies of free living individuals. J. Nutr.136(5), 1334–1340 (2006).
   PubMedGoogle Scholar
• Bingham SA, Gill C, Welch A et al. Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int. J. Epidemiol.26(Suppl. 1), S137–S151 (1997).
   Web of Science ®Google Scholar
• Turban S, Miller ER, Ange B, Appel LJ. Racial differences in urinary potassium excretion. J. Am. Soc. Nephrol.19(7), 1396–1402 (2008).
   PubMed Web of Science ®Google Scholar
• Conlin PR, Chow D, Miller ER et al. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am. J. Hypertens.13(9), 949–955 (2000).
   PubMed Web of Science ®Google Scholar
• Hu G, Jousilahti P, Peltonen M, Lindström J, Tuomilehto J. Urinary sodium and potassium excretion and the risk of Type 2 diabetes: a prospective study in Finland. Diabetologia48(8), 1477–1483 (2005).
   PubMed Web of Science ®Google Scholar
• Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Diet and risk of clinical diabetes in women. Am. J. Clin. Nutr.55(5), 1018–1023 (1992).
   PubMed Web of Science ®Google Scholar
• Liese AD, Nichols M, Sun X et al. Adherence to the DASH diet is inversely associated with incidence of Type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care32(8), 1434–1436 (2009).
   PubMed Web of Science ®Google Scholar
• Blumenthal JA, Babyak MA, Sherwood A et al. Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids. Hypertension55(5), 1199–1205 (2010).
   PubMed Web of Science ®Google Scholar
• Carter P, Gray LJ, Troughton J, Khunti K, Davies MJ. Fruit and vegetable intake and incidence of Type 2 diabetes mellitus: systematic review and meta-analysis. BMJ341, c4229 (2010).
   PubMed Web of Science ®Google Scholar
• Been LF, Ralhan S, Wander GS et al. Variants in KCNQ1 increase Type II diabetes susceptibility in South Asians: a study of 3,310 subjects from India and the US. BMC Med. Genet.12, 18 (2011).
   PubMedGoogle Scholar
• Zhou JB, Yang JK, Zhao L, Xin Z. Variants in KCNQ1, AP3S1, MAN2A1, and ALDH7A1 and the risk of Type 2 diabetes in the Chinese Northern Han population: a case–control study and meta-analysis. Med. Sci. Monit.16(6), BR179–BR183 (2010).
   PubMed Web of Science ®Google Scholar